ATAI Life Sciences BV (ATAI) — Cash Flow Quality Index
Latest as of September 2023:
-0.42x
ATAI Life Sciences BV (ATAI) has a Cash Flow Quality Index of -0.42x as of September 2023. Operating cash flow of $-18.43 Million is below net income of $43.37 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ATAI long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-0.42x
Operating CF / Net Income
Operating Cash Flow
$-18.43 Million
USD
Net Income
$43.37 Million
USD
Data as of
Sep 2023
Most recent filing
Annual Cash Flow Quality Index for ATAI Life Sciences BV (None–None)
Year-by-year earnings quality comparison for ATAI Life Sciences BV. For live market cap and the full company financial profile, see ATAI market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.